• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共病物质使用与精神分裂症的起病年龄

Comorbid substance use and age at onset of schizophrenia.

作者信息

Barnes Thomas R E, Mutsatsa Stanley H, Hutton Sam B, Watt Hilary C, Joyce Eileen M

机构信息

Department of Psychological Medicine, Imperial College Faculty of Medicine, Charing Cross Campus, St Dunstan's Road, London W6 8RP, UK.

出版信息

Br J Psychiatry. 2006 Mar;188:237-42. doi: 10.1192/bjp.bp.104.007237.

DOI:10.1192/bjp.bp.104.007237
PMID:16507965
Abstract

BACKGROUND

Substance use may be a risk factor for the onset of schizophrenia.

AIMS

To examine the association between substance use and age at onset in substance use and age at onset in a UK, inner-city sample of people with recent-onset schizophrenia.

METHOD

The study sample consisted of 152 people recruited to the West London First-Episode Schizophrenia Study. Self-reported data on drug and alcohol use, as well as information on age at onset of psychosis, were collected. Mental state, cognition (IQ, memory and executive function) and social function were also assessed.

RESULTS

In total, 60% of the participants were smokers, 27% reported a history of problems with alcohol use, 35% reported current substance use (not including alcohol), and 68% reported lifetime substance use (cannabis and psychostimulants were most commonly used). Cannabis use and gender had independent effects on age at onset of psychosis, after adjusting for alcohol misuse and use of other drugs.

CONCLUSIONS

The strong association between self-reported cannabis use and earlier onset of psychosis provides further evidence that schizophrenia may be precipitated by cannabis use and/or that the early onset of symptoms is a risk factor for cannabis use.

摘要

背景

物质使用可能是精神分裂症发病的一个风险因素。

目的

在英国一个市中心近期发病的精神分裂症患者样本中,研究物质使用与发病年龄之间的关联。

方法

研究样本包括152名招募至西伦敦首发精神分裂症研究的患者。收集了关于药物和酒精使用的自我报告数据,以及精神病发病年龄的信息。还评估了精神状态、认知(智商、记忆和执行功能)和社会功能。

结果

总体而言,60%的参与者吸烟,27%报告有酒精使用问题史,35%报告目前使用物质(不包括酒精),68%报告终生使用物质(最常用的是大麻和精神兴奋剂)。在调整了酒精滥用和其他药物使用后,大麻使用和性别对精神病发病年龄有独立影响。

结论

自我报告的大麻使用与较早的精神病发病之间的强烈关联提供了进一步的证据,表明精神分裂症可能由大麻使用引发和/或症状的早期出现是大麻使用的一个风险因素。

相似文献

1
Comorbid substance use and age at onset of schizophrenia.共病物质使用与精神分裂症的起病年龄
Br J Psychiatry. 2006 Mar;188:237-42. doi: 10.1192/bjp.bp.104.007237.
2
Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.大麻、易感性与精神分裂症的发病:流行病学视角
Aust N Z J Psychiatry. 2000 Jun;34(3):468-75. doi: 10.1080/j.1440-1614.2000.00736.x.
3
[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].[共病物质使用对患有精神病性或心境障碍的受试者神经心理表现的影响]
Encephale. 2002 Mar-Apr;28(2):160-8.
4
Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London.精神分裂症患者中并存的非酒精物质滥用:伦敦市中心的流行病学研究
Br J Psychiatry. 2001 Dec;179:509-13. doi: 10.1192/bjp.179.6.509.
5
The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders.首次使用酒精和尼古丁的年龄与大麻使用的开始和大麻使用障碍的进展的相关性。
Drug Alcohol Depend. 2012 Jun 1;123(1-3):48-56. doi: 10.1016/j.drugalcdep.2011.10.013. Epub 2011 Nov 8.
6
Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.有和无精神病障碍者的烟草、酒精和大麻使用相关的感知风险。
Addict Behav. 2013 Jun;38(6):2246-51. doi: 10.1016/j.addbeh.2013.02.003. Epub 2013 Feb 18.
7
Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.精神分裂症共病物质使用的自然主义随访:西伦敦首发研究
Psychol Med. 2008 Jan;38(1):79-88. doi: 10.1017/S0033291707000797. Epub 2007 May 29.
8
Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.近期发病精神分裂症中的共病物质滥用与神经认知功能
Eur Arch Psychiatry Clin Neurosci. 2007 Jun;257(4):203-10. doi: 10.1007/s00406-006-0707-x. Epub 2006 Nov 25.
9
Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.大麻使用与首发精神病:与躁狂和精神病症状以及发病年龄的关系。
Psychol Med. 2014 Feb;44(3):499-506. doi: 10.1017/S0033291713000883. Epub 2013 May 24.
10
Substance abuse and the onset of schizophrenia.药物滥用与精神分裂症的发病
Biol Psychiatry. 1996 Dec 1;40(11):1155-63. doi: 10.1016/S0006-3223(95)00609-5.

引用本文的文献

1
Prevalence and factors influencing low social support from family, friends, and significant others among people with mental illness attending psychiatric outpatient clinics in Gondar, Ethiopia.埃塞俄比亚贡德尔地区精神科门诊就诊的精神疾病患者中,来自家人、朋友及重要他人的低社会支持的患病率及影响因素。
BMC Psychiatry. 2025 Apr 28;25(1):429. doi: 10.1186/s12888-025-06889-y.
2
Azithromycin-induced Adolescent Manic Episode with Psychotic Features: A Case Report.阿奇霉素诱发的伴有精神病性特征的青少年躁狂发作:一例报告
Innov Clin Neurosci. 2025 Mar 1;22(1-3):54-57. eCollection 2025 Jan-Mar.
3
Research landscape analysis on dual diagnosis of substance use and mental health disorders: key contributors, research hotspots, and emerging research topics.
物质使用与精神健康障碍双重诊断的研究态势分析:主要贡献者、研究热点及新兴研究课题
Ann Gen Psychiatry. 2024 Aug 30;23(1):32. doi: 10.1186/s12991-024-00517-x.
4
Examining the impact of substance use on hospital length of stay in schizophrenia spectrum disorder: a retrospective analysis.探讨物质使用对精神分裂症谱系障碍患者住院时间的影响:一项回顾性分析。
BMC Med. 2024 Jun 10;22(1):233. doi: 10.1186/s12916-024-03447-3.
5
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study.兴奋剂使用模式的差异及其对首发精神病发病率的影响:EUGEI 研究分析。
Schizophr Bull. 2023 Sep 7;49(5):1269-1280. doi: 10.1093/schbul/sbad013.
6
The prevalence and determinant factors of substance use among the youth in Ethiopia: A multilevel analysis of Ethiopian Demographic and Health Survey.埃塞俄比亚青年物质使用的患病率及决定因素:基于埃塞俄比亚人口与健康调查的多层次分析
Front Psychiatry. 2023 Mar 23;14:1096863. doi: 10.3389/fpsyt.2023.1096863. eCollection 2023.
7
Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM study.阿立哌唑一月注射一次制剂治疗伴有和不伴有共病物质使用的精神分裂症的症状和整体功能有效 - ReLiAM 研究的事后分析。
BMC Psychiatry. 2022 Dec 8;22(1):773. doi: 10.1186/s12888-022-04397-x.
8
Substance use Specificities in Women with Psychosis: A Critical Review.女性精神病患者物质使用的特异性:批判性评价。
Curr Neuropharmacol. 2023;21(9):1953-1963. doi: 10.2174/1570159X21666221129113942.
9
Artificial intelligence-assisted psychosis risk screening in adolescents: Practices and challenges.青少年人工智能辅助精神病风险筛查:实践与挑战
World J Psychiatry. 2022 Oct 19;12(10):1287-1297. doi: 10.5498/wjp.v12.i10.1287.
10
Polypharmacotherapy in Psychiatry: Global Insights from a Rapid Online Survey of Psychiatrists.精神科的多药联合治疗:基于精神科医生快速在线调查的全球洞察
J Clin Med. 2022 Apr 11;11(8):2129. doi: 10.3390/jcm11082129.